(lp0
S'Better Buy: Agenus Inc. vs. Celldex Therapeutics Motley Fool - Mar 10, 2017 Agenus Inc  and Celldex Therapeutics, Inc.  bear an uncanny resemblance to each other. Both clinical-stage biotechs are focused on developing novel cancer therapies and reported clinical-trial failures with vaccine&nbsp;...'
p1
aS"Agenus Inc.  Soars 5.53% on March 15 Equities.com - 12 hours ago Agenus Inc.  had a good day on the market for Wednesday March 15 as shares jumped 5.53% to close at $4.20. About 1.25 million shares traded hands on 5,150 trades for the day, compared with an average daily volume of 1.24 million shares out of a&nbsp;...Agenus Inc. : Thoughts on the Momentum - Post AnalystTop Negative Stock: Agenus Inc.'s  stock price completes at $3.98 with ... - WsNews 4investors"
p2
aS'Troubling Trial Data Weighed on Agenus Inc Stock Today Motley Fool - Feb 22, 2017 Shares of Agenus Inc , a biopharmaceutical company developing cancer therapies, had fallen about 14.5% as of 3:20 p.m.Trials Of Agenus Inc  Cancer Vaccine Ends In Absolute Failure - Market Exclusive'
p3
aS'Agenus Inc.  Plunges 5.24% on March 14 Equities.com - Mar 14, 2017 Agenus Inc.  had a rough trading day for Tuesday March 14 as shares tumbled 5.24%, or a loss of $-0.22 per share, to close at $3.98.Agenus Inc.  currently has Insider Ownership of 22% - TopChronicleThe Agenus Inc Expected to Post Q1 2017 Earnings of  Per Share  - Petro Global News 24'
p4
aS'Agenus  Reports Narrower-than-Expected Loss in Q4 Zacks.com - Mar 10, 2017 Agenus Inc.  reported fourth-quarter 2016 loss of 30 cents per share , narrower than the Zacks Consensus Estimate of a loss of 33 cents but wider than the year-ago loss of 18 cents.Agenus reports 4Q loss - Yahoo Finance'
p5
aS'Agenus Inc.: Agenus Reports Fourth Quarter and Full Year 2016 Results The Wall Street Transcript - Mar 9, 2017 LEXINGTON, Mass., March 9, 2017/PRNewswire / -- Agenus Inc. , an immuno-oncology  company with a pipeline of immune checkpoint antibodies and cancer vaccines, provided a corporate update and reported financial results for the&nbsp;...AGENUS INC.  Files An 8-K Results of Operations and Financial ... - Market ExclusiveAgenus  Reports Narrower-than-Expected Q4 Loss - Yahoo Finance'
p6
aS"Stock Scanner: Watching the Numbers on Agenus Inc  Baxter Review - 9 hours ago Let's take a look at some recent technical levels on shares of Agenus Inc . The current 14-day RSI is noted at 47.87, the 7-day is 46.14, and the 3-day is seen at 42.69."
p7
aS"Agenus Inc.  Moves Higher on Volume Spike for February 14 Equities.com - Feb 14, 2017 Agenus Inc.  traded on unusually high volume on Feb. 14, as the stock gained 6.8% to close at $4.40. On the day, Agenus Inc. saw 6.58 million shares trade hands on 21,630 trades. Considering that the stock averages only a daily volume of 899,126&nbsp;...Trader's Round Up: Agenus Inc.  - TopChronicleAgenus Inc.  Recent Ownership Changes - Post Analyst"
p8
aS"Agenus Inc.  Soars 6.62% on February 20 Equities.com - Feb 20, 2017 Agenus Inc.  had a good day on the market for Monday February 20 as shares jumped 6.62% to close at $4.51. About 2.13 million shares traded hands on 7,923 trades for the day, compared with an average daily volume of 1.26 million shares out of a&nbsp;...Agenus Inc.  Major Shareholder Purchases $60000000.00 in Stock - Chaffey BreezeInvestor's Watch List: Agenus Inc.  - TopChronicle"
p9
aS'Agenus Inc.  Moves Lower on Volume Spike for February 16 Equities.com - Feb 16, 2017 Agenus Inc.  traded on unusually high volume on Feb. 16, as the stock lost 5.37% to close at $4.23. On the day, Agenus Inc. saw 1.91 million shares trade hands on 10,541 trades. Considering that the stock averages only a daily volume of 1.14 ...Two Stocks in Concentration: Agenus Inc. , First Bancorp  - FactsReporterAgenus Inc.  Major Shareholder Corp Incyte Acquires 10000000 Shares of Stock - Sports Perspectives'
p10
a.